Loading…

Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience

Saved in:

Bibliographic Details
Published in:	Annals of hematology 2013-01, Vol.92 (2), p.263-265
Main Authors:	Efthimia, Vlachaki, Neokleous, Nikolaos, Agapidou, Alexandra, Economou, Marina, Vetsiou, Evaggelia, Teli, Aikaterini, Perifanis, Vasileios
Format:	Article
Language:	English
Subjects:	Adult Benzoates - adverse effects Benzoates - therapeutic use beta-Thalassemia - blood beta-Thalassemia - complications beta-Thalassemia - surgery beta-Thalassemia - therapy Chelation Therapy - adverse effects Child Child, Preschool Female Greece - epidemiology Hematology Humans Hypercalciuria - etiology Hyperuricemia - etiology Iron Chelating Agents - adverse effects Iron Chelating Agents - therapeutic use Iron Overload - drug therapy Iron Overload - etiology Letter to the Editor Male Medicine Medicine & Public Health Nephrolithiasis - blood Nephrolithiasis - chemically induced Nephrolithiasis - epidemiology Nephrolithiasis - etiology Oncology Postoperative Complications - blood Postoperative Complications - chemically induced Postoperative Complications - epidemiology Postoperative Complications - etiology Pyridones - therapeutic use Splenectomy Transfusion Reaction Triazoles - adverse effects Triazoles - therapeutic use Young Adult
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!